2254 - Durability and effectiveness of fostemsavir in heavily treatment-experienced people with HIV

Saturday, October 22, 2022

12:15 PM – 12:45 PM US ET

Location: Hall BC - Arena 2

All relevant financial disclosures have been mitigated.

Rapid Fire Presenter(s)

Ricky K. Hsu, MD (he/him/his)

National Medical Director of Clinical Standards, Policy, & Education\ Associate Professor of Medicine
AIDS Healthcare Foundation\ NYU School of Medicine
New York, New York, United States

Disclosure: Disclosure(s): Gilead: Honoraria (); Merck: Honoraria (); ViiV: Advisor/Consultant (), Grant/Research Support (), Honoraria ()

Co-Author(s)

LB

Laurence Brunet, PhD

Director of Epidemiology
Epividian, Inc.
Durham, North Carolina, United States

Disclosure: Disclosure(s): AIDS Healthcare Foundation: Client of my employer (); EMD Serono: Client of my employer (); Gilead Sciences: Client of my employer (); Janssen: Client of my employer (); Merck & Co: Client of my employer (); TheraTechnologies: Client of my employer (); ViiV Healthcare: Client of my employer ()
Jennifer S. Fusco, BS

Chief Science Officer
Epividian, Inc.
Durham, North Carolina, United States

Disclosure: Disclosure(s): AIDS Healthcare Foundation: Client of my employer (); EMD Serono: Client of my employer (); Gilead Sciences: Client of my employer (); Janssen: Client of my employer (); Merck & Co.: Client of my employer (); TheraTechnologies: Client of my employer (); ViiV Healthcare: Client of my employer ()
CH

Cassidy Henegar, PhD, MSPH

Director
ViiV Healthcare
Chapel Hill, North Carolina, United States

Disclosure: Disclosure(s): GlaxoSmithKline: Stocks/Bonds (); ViiV Healthcare: full-time employee ()
Vani Vannappagari, MBBS, MPH, PhD

Global Head, Epidemiology & Real World Evidence
ViiV Healthcare
Research Triangle Park, North Carolina, United States

Disclosure: Disclosure(s): ViiV Healthcare: I am full time employee of ViiV Healthcare and receive GlaxoSmithKline stock as part of my compensation package (), Stocks/Bonds ()
AC

Andrew Clark, MD

Global Medical Lead
ViiV Healthcare, Brentford, UK
Brentford, England, United Kingdom

Disclosure: Disclosure(s): ViiV Healthcare: Employee (), Stocks/Bonds ()
PL

Philip C. Lackey, MD

Physician
Signature Healthcare
Charlotte, North Carolina, United States

Disclosure: Disclosure(s): No financial relationships to disclose
Gerald Pierone, Jr., MD (he/him/his)

Medical Director
Whole Family Health Center
Vero Beach, Florida, United States

Disclosure: Disclosure(s): Gilead: Grant/Research Support (); GSK-VIIV: Grant/Research Support ()
GF

Gregory P. Fusco, MD, MPH

Chief Executive Officer & Chief Medical Officer
Epividian, Inc.
Durham, North Carolina, United States

Disclosure: Disclosure(s): AIDS Healthcare Foundation: Client of employer (); EMD: Grant/Research Support (); Gilead Sciences: Client of employer (); Janssen: Client of employer (); Merck & Co.: Client of employer (); Theratechnologies: Client of employer (); ViiV Healthcare: Client of employer ()

Disclosure(s):

Ricky K. Hsu, MD: Gilead: Honoraria (); Merck: Honoraria (); ViiV: Advisor/Consultant (), Grant/Research Support (), Honoraria ()

Laurence Brunet, PhD: AIDS Healthcare Foundation: Client of my employer (); EMD Serono: Client of my employer (); Gilead Sciences: Client of my employer (); Janssen: Client of my employer (); Merck & Co: Client of my employer (); TheraTechnologies: Client of my employer (); ViiV Healthcare: Client of my employer ()

Jennifer S. Fusco, BS: AIDS Healthcare Foundation: Client of my employer (); EMD Serono: Client of my employer (); Gilead Sciences: Client of my employer (); Janssen: Client of my employer (); Merck & Co.: Client of my employer (); TheraTechnologies: Client of my employer (); ViiV Healthcare: Client of my employer ()

Cassidy Henegar, PhD, MSPH: GlaxoSmithKline: Stocks/Bonds (); ViiV Healthcare: full-time employee ()

Vani Vannappagari, MBBS, MPH, PhD: ViiV Healthcare: I am full time employee of ViiV Healthcare and receive GlaxoSmithKline stock as part of my compensation package (), Stocks/Bonds ()

Andrew Clark, MD: ViiV Healthcare: Employee (), Stocks/Bonds ()

Philip C. Lackey, MD: No financial relationships to disclose

Gerald Pierone, MD, Jr.: Gilead: Grant/Research Support (); GSK-VIIV: Grant/Research Support ()

Gregory P. Fusco, MD, MPH: AIDS Healthcare Foundation: Client of employer (); EMD: Grant/Research Support (); Gilead Sciences: Client of employer (); Janssen: Client of employer (); Merck & Co.: Client of employer (); Theratechnologies: Client of employer (); ViiV Healthcare: Client of employer ()